Skip to main content
B

BPH GLOBAL LTD — Investor Relations & Filings

Ticker · BP8 ISIN · AU0000284366 LEI · 98450003FC85745AF196 ASX Professional, scientific and technical activities
Open in API
Filings indexed 778 across all filing types
Latest filing 2026-04-26 Board/Management Inform…
Country AU Australia
Listing ASX BP8

About BPH GLOBAL LTD

https://bphglobal.com

BPH Global Ltd is a biotechnology firm focused on the research, development, and commercialization of plant-based health and wellness products. The company specializes in the sustainable sourcing and processing of high-value botanical ingredients, including seaweed, bird's nest, and traditional Chinese medicine components. By leveraging advanced extraction and cultivation technologies, BPH Global aims to deliver premium functional foods and nutraceuticals to the global market. Its operations encompass the entire supply chain, from raw material procurement to the distribution of finished consumer goods. The company prioritizes scientific innovation and quality control to meet the growing demand for natural health solutions, particularly within the Asia-Pacific region. Through its integrated business model, it seeks to provide scalable solutions for the health supplement and functional food sectors.

Recent filings

Filing Released Lang Actions
Appointment of Chief Scientific Officer 2 pages 117.1KB
Board/Management Information Classification · 1% confidence The document is an ASX release announcing the appointment of a new Chief Scientific Officer (Ms Ifat Mazouz) to the company’s executive leadership team, including details of her responsibilities and effective date. This fits the definition of a Board/Management Information announcement regarding changes in senior management.
2026-04-26 English
Sale of China Birds Nest Business 2 pages 132.2KB
M&A Activity Classification · 1% confidence The document is an ASX release announcing a strategic divestment: the sale of its China-based bird’s nest business. It describes the sale agreement, key commercial terms (equity sale structure, consideration, completion conditions), and positions this as a corporate transaction disposing of a non-core business. There is no indication of it being an earnings release, share issuance, director dealing, or regulatory prospectus; rather, it is a corporate transaction announcement. The closest fit in our filing taxonomy is M&A Activity (Code: TAR), which covers announcements related to mergers, acquisitions, disposals, and takeover bids. Therefore, the correct classification is TAR.
2026-04-23 English
Development of Seaweed-based anti-aging supplement 2 pages 153.0KB
Regulatory Filings Classification · 1% confidence The document is an ASX Release announcing that BPH Global’s Indonesian subsidiary has formally entered Stage 2 of its collaboration with Indonesia’s National Research and Innovation Agency (BRIN), detailing project scope, agreements executed, funding contributions, timelines, and strategic context. It does not present financial results (ER or IR), is not an investor presentation (IP), not a capital-raising or share issue notice (CAP or SHA), and is not a full annual/interim report (10-K or IR). It is a regulatory announcement of a corporate development that does not fit more specific categories, making it a fallback Regulatory Filing (RNS).
2026-04-22 English
BPH Global Secures Coastal Site for Seaweed Cultivation 2 pages 209.1KB
Regulatory Filings Classification · 1% confidence The document is an ASX market release announcing execution of a binding land lease for a new seaweed cultivation site. It is not an AGM presentation, financial results announcement, dividend notice, share issue, management changes, or any other specific category. It is not reporting detailed financial performance, nor is it an investor presentation or part of a regulatory stress test. This type of miscellaneous market announcement fits the fallback “Regulatory Filings” category.
2026-04-21 English
BPH Global Launches New Investor Hub 1 page 104.7KB
Regulatory Filings Classification · 1% confidence The document is an ASX release announcing the launch of a new investor website/platform. It does not present financial results, voting information, share issues, or other specific transaction details. It is a general regulatory announcement that does not fit into any of the more specific categories, so it falls under ‘Regulatory Filings (RNS)’ as a miscellaneous ASX announcement.
2026-04-19 English
Notification of cessation of securities - BP8 5 pages 16.1KB
Share Issue/Capital Change Classification · 1% confidence The document is an ASX Appendix 3H form notifying the cessation (expiry) of previously issued equity-linked securities (options). This is a change in the company’s issued capital structure rather than financial results or a meeting notice. It therefore falls under Share Issue/Capital Change (SHA).
2026-04-15 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.